Coronary artery superoxide production and nox isoform expression in human coronary artery disease
- PMID: 16293794
- DOI: 10.1161/01.ATV.0000196651.64776.51
Coronary artery superoxide production and nox isoform expression in human coronary artery disease
Abstract
Background: Oxidative stress plays important role in the pathogenesis of atherosclerosis and coronary artery disease (CAD). We aimed to determine the sources and selected molecular mechanisms of oxidative stress in CAD.
Methods and results: We examined basal and NAD(P)H oxidase-mediated superoxide (O2*-) production using lucigenin chemiluminescence, ferricytochrome c and dihydroethidium fluorescence in human coronary arteries from 19 CAD and 17 non-CAD patients undergoing heart transplantation. NAD(P)H oxidase subunits and xanthine oxidase expression were measured. Superoxide production was greater in coronary arteries from patients with CAD, even in vessels without overt atherosclerotic plaques, and was doubled within branching points of coronary arteries. Studies using pharmacological inhibitors and specific substrates showed that NAD(P)H oxidases (60%) and xanthine oxidase (25%) are primary sources of O2*- in CAD. Losartan significantly inhibited superoxide production in coronary arteries. NAD(P)H oxidase activity and protein levels of the NADPH oxidase subunits p22phox, p67phox, and p47phox were significantly increased in CAD, as were mRNA levels for p22phox and nox2, and no NAD(P)H oxidase subunit mRNA levels correlated with NAD(P)H oxidase activity in vessels from individual patients. Activity and protein expression of xanthine oxidase were increased in CAD, whereas xanthine dehydrogenase levels were not changed.
Conclusions: Increased expression and activity of NAD(P)H oxidase subunits and xanthine oxidase, in part mediated through angiotensin II and PKC-dependent pathways, are important mechanisms underlying increased oxidative stress in human coronary artery disease.
Similar articles
-
Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants.Eur J Clin Invest. 2005 May;35(5):305-14. doi: 10.1111/j.1365-2362.2005.01500.x. Eur J Clin Invest. 2005. PMID: 15860042 Review.
-
C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase.Arterioscler Thromb Vasc Biol. 2005 May;25(5):995-1001. doi: 10.1161/01.ATV.0000159890.10526.1e. Epub 2005 Feb 17. Arterioscler Thromb Vasc Biol. 2005. PMID: 15718491
-
Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1614-20. doi: 10.1161/01.ATV.0000139011.94634.9d. Epub 2004 Jul 15. Arterioscler Thromb Vasc Biol. 2004. PMID: 15256399
-
High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase.Circulation. 2003 Sep 9;108(10):1253-8. doi: 10.1161/01.CIR.0000079165.84309.4D. Epub 2003 Jul 21. Circulation. 2003. PMID: 12874194
-
Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors.J Physiol Pharmacol. 2002 Dec;53(4 Pt 1):515-24. J Physiol Pharmacol. 2002. PMID: 12512689 Review.
Cited by
-
Systemic and local vascular inflammation and arterial reactive oxygen species generation in patients with advanced cardiovascular diseases.Front Cardiovasc Med. 2023 Sep 7;10:1230051. doi: 10.3389/fcvm.2023.1230051. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37745103 Free PMC article.
-
Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation.Antioxidants (Basel). 2023 May 30;12(6):1185. doi: 10.3390/antiox12061185. Antioxidants (Basel). 2023. PMID: 37371915 Free PMC article. Review.
-
ROS inhibition increases KDM6A-mediated NOX2 transcription and promotes macrophages oxidative stress and M1 polarization.Cell Stress Chaperones. 2023 Jul;28(4):375-384. doi: 10.1007/s12192-023-01347-8. Epub 2023 May 4. Cell Stress Chaperones. 2023. PMID: 37140849 Free PMC article.
-
Catechins: Protective mechanism of antioxidant stress in atherosclerosis.Front Pharmacol. 2023 Mar 24;14:1144878. doi: 10.3389/fphar.2023.1144878. eCollection 2023. Front Pharmacol. 2023. PMID: 37033663 Free PMC article. Review.
-
Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets.Cell Mol Biol Lett. 2023 Mar 9;28(1):21. doi: 10.1186/s11658-023-00423-2. Cell Mol Biol Lett. 2023. PMID: 36890458 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous